Why JPMorgan Chase (JPM) Is Down 5.8% After Apple Card Charge and Rate-Cap Scrutiny - And What's Next
JPMorgan Chase & Co. JPM | 294.60 | -0.26% |
- Earlier this week, JPMorgan Chase reported fourth-quarter 2025 results showing higher net interest income but a 7% drop in quarterly profit to US$13.03 billion, alongside lower-than-expected investment banking fees and a US$2.20 billion credit reserve tied to its deal to take over the Apple Card portfolio from Goldman Sachs.
- At the same time, President Trump’s call for a one-year 10% cap on credit card interest rates has put JPMorgan’s highly profitable card business under policy scrutiny, prompting the bank’s executives to warn that such a move could materially change its card operations and reduce credit access for many borrowers.
- We’ll now examine how JPMorgan’s Apple Card acquisition costs and mounting political pressure on credit card pricing could reshape its investment narrative.
The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
JPMorgan Chase Investment Narrative Recap
To own JPMorgan Chase, you have to believe its scale, diversified earnings and heavy tech spending can keep compounding value even when individual quarters are messy. The latest results and the US$2.20 billion Apple Card reserve tug at near term profitability, while the proposed 10% cap on credit card rates is the clearest immediate threat to its card driven growth story and a more material risk than the quarter’s revenue miss itself.
Against that backdrop, the Apple Card portfolio deal that drove the reserve charge also directly links into a key catalyst: expanding JPMorgan’s digital card and payments footprint. How smoothly this acquisition is absorbed, and whether the card business remains attractive if pricing is constrained by policy, will matter far more for the stock than shorter term items like the recently completed US$9,142.03 million buyback, which mainly fine tunes capital return.
Yet beneath JPMorgan’s size, investors should not ignore how fast political scrutiny of credit products can change the rules of the game...
JPMorgan Chase's narrative projects $186.7 billion revenue and $55.5 billion earnings by 2028.
Uncover how JPMorgan Chase's forecasts yield a $328.09 fair value, a 7% upside to its current price.
Exploring Other Perspectives
Some analysts were far more optimistic, assuming revenue could reach about US$194.8 billion and earnings US$59.0 billion by 2028, but the latest Apple Card hit and credit card rate cap risk show how quickly those tech driven upside stories can be tested, so you should weigh both the upbeat and more cautious views before deciding which narrative feels more realistic.
Explore 23 other fair value estimates on JPMorgan Chase - why the stock might be worth as much as 29% more than the current price!
Build Your Own JPMorgan Chase Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your JPMorgan Chase research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free JPMorgan Chase research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate JPMorgan Chase's overall financial health at a glance.
Ready For A Different Approach?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Find companies with promising cash flow potential yet trading below their fair value.
- We've found 12 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
- AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
